Literature DB >> 24659265

Stemness state regulators SALL4 and SOX2 are involved in progression and invasiveness of esophageal squamous cell carcinoma.

Mohammad Mahdi Forghanifard1, Sima Ardalan Khales, Afsaneh Javdani-Mallak, Abolfazl Rad, Moein Farshchian, Mohammad Reza Abbaszadegan.   

Abstract

Cancer stem cells, as a subgroup of tumor cells, resemble critical properties of embryonic stem cells (ESCs) such as self-renewal and maintenance of stemness state. SALL4 and SOX2 are two main transcription factors involving in maintenance of pluripotency, self-renewal and cell fate decision in ESCs. In this study, we aimed to elucidate the expression levels of these important transcription factors in esophageal squamous cell carcinoma (ESCC) and to reveal their probable roles in maintenance and progression of the disease. The expression level of SALL4 and SOX2 was analyzed in fresh tumoral tissues in comparison with distant tumor-free tissues of 50 ESCC patients by relative comparative real-time PCR. SALL4 and SOX2 were overexpressed in 64 and 32% of tumor samples, respectively, in significant correlation with each other (p = 0.028). There was a significantly inverse correlation between low level of SALL4 expression and metastasis of tumor cells into the lymph nodes (p = 0.035). Furthermore, co-overexpression of the genes was significantly correlated with the depth of tumor invasion (p = 0.045) and metastasis to the lymph nodes (p = 0.049). SALL4 and SOX2 are co-overexpressed in ESCC and have a significant correlation with invasion and metastasis of the disease. To the best of our knowledge, this is the first report of SALL4 clinical relevance in ESCC to date. The clinical consequences of SALL4-SOX2 association suggest a possible functional interaction between these factors in regulation of ESCC maintenance and aggressiveness and introduce these regulators of stemness state as potentially interesting therapeutic targets to bring new opportunities for onco-therapeutic modalities.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24659265     DOI: 10.1007/s12032-014-0922-7

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  34 in total

1.  SALL4 is essential for cancer cell proliferation and is overexpressed at early clinical stages in breast cancer.

Authors:  Daisuke Kobayashi; Kageaki Kuribayshi; Maki Tanaka; Naoki Watanabe
Journal:  Int J Oncol       Date:  2011-01-27       Impact factor: 5.650

2.  Sall4 is essential for stabilization, but not for pluripotency, of embryonic stem cells by repressing aberrant trophectoderm gene expression.

Authors:  Shunsuke Yuri; Sayoko Fujimura; Keisuke Nimura; Naoki Takeda; Yayoi Toyooka; Yu-Ichi Fujimura; Hiroyuki Aburatani; Kiyoe Ura; Haruhiko Koseki; Hitoshi Niwa; Ryuichi Nishinakamura
Journal:  Stem Cells       Date:  2009-04       Impact factor: 6.277

3.  Clinicopathologic implications of EpCAM and Sox2 expression in breast cancer.

Authors:  Nehad M R Abd El-Maqsoud; Dalia M Abd El-Rehim
Journal:  Clin Breast Cancer       Date:  2013-09-27       Impact factor: 3.225

Review 4.  The therapeutic promise of the cancer stem cell concept.

Authors:  Natasha Y Frank; Tobias Schatton; Markus H Frank
Journal:  J Clin Invest       Date:  2010-01       Impact factor: 14.808

5.  SWI/SNF-Brg1 regulates self-renewal and occupies core pluripotency-related genes in embryonic stem cells.

Authors:  Benjamin L Kidder; Stephen Palmer; Jason G Knott
Journal:  Stem Cells       Date:  2009-02       Impact factor: 6.277

6.  Evidence that SOX2 overexpression is oncogenic in the lung.

Authors:  Yun Lu; Christopher Futtner; Jason R Rock; Xia Xu; Walter Whitworth; Brigid L M Hogan; Mark W Onaitis
Journal:  PLoS One       Date:  2010-06-10       Impact factor: 3.240

7.  Sox2 cooperates with inflammation-mediated Stat3 activation in the malignant transformation of foregut basal progenitor cells.

Authors:  Kuancan Liu; Ming Jiang; Yun Lu; Hao Chen; Jun Sun; Shaoping Wu; Wei-Yao Ku; Hiroshi Nakagawa; Yoshiaki Kita; Shoji Natsugoe; Jeffrey H Peters; Anil Rustgi; Mark W Onaitis; Amy Kiernan; Xiaoxin Chen; Jianwen Que
Journal:  Cell Stem Cell       Date:  2013-03-07       Impact factor: 24.633

8.  An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors.

Authors:  Ittai Ben-Porath; Matthew W Thomson; Vincent J Carey; Ruping Ge; George W Bell; Aviv Regev; Robert A Weinberg
Journal:  Nat Genet       Date:  2008-05       Impact factor: 38.330

9.  Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas.

Authors:  Marta M Alonso; Ricardo Diez-Valle; Lorea Manterola; Angel Rubio; Dan Liu; Nahir Cortes-Santiago; Leire Urquiza; Patricia Jauregi; Adolfo Lopez de Munain; Nicolás Sampron; Ander Aramburu; Sonia Tejada-Solís; Carmen Vicente; María D Odero; Eva Bandrés; Jesús García-Foncillas; Miguel A Idoate; Frederick F Lang; Juan Fueyo; Candelaria Gomez-Manzano
Journal:  PLoS One       Date:  2011-11-01       Impact factor: 3.240

10.  Role of SALL4 in the progression and metastasis of colorectal cancer.

Authors:  Mohammad Mahdi Forghanifard; Meysam Moghbeli; Reza Raeisossadati; Alireza Tavassoli; Afsaneh Javdani Mallak; Samaneh Boroumand-Noughabi; Mohammad Reza Abbaszadegan
Journal:  J Biomed Sci       Date:  2013-01-30       Impact factor: 8.410

View more
  47 in total

1.  Predicting the molecular role of MEIS1 in esophageal squamous cell carcinoma.

Authors:  Abolfazl Rad; Moein Farshchian; Mohammad Mahdi Forghanifard; Maryam M Matin; Ahmad Reza Bahrami; Dirk Geerts; Azadeh A'rabi; Bahram Memar; Mohammad Reza Abbaszadegan
Journal:  Tumour Biol       Date:  2015-08-28

2.  SALL4 as a new biomarker for early colorectal cancers.

Authors:  Sima Ardalan Khales; Mohammad Reza Abbaszadegan; Abbas Abdollahi; Reza Raeisossadati; Mohsen Fallah Tousi; Mohammad Mahdi Forghanifard
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-26       Impact factor: 4.553

3.  Crosstalk between SHH and stemness state signaling pathways in esophageal squamous cell carcinoma.

Authors:  Maryam Najafi; Mohammad Reza Abbaszadegan; Abolfazl Rad; Mahtab Dastpak; Samaneh Boroumand-Noughabi; Mohammad Mahdi Forghanifard
Journal:  J Cell Commun Signal       Date:  2016-11-30       Impact factor: 5.782

4.  Stemness-Related Markers in Cancer.

Authors:  Wenxiu Zhao; Yvonne Li; Xun Zhang
Journal:  Cancer Transl Med       Date:  2017-06-08

5.  High sex determining region Y-box 2 (SOX2) expression correlates with absence of nodal metastasis in esophageal squamous cell carcinoma.

Authors:  Wen-Yu Chuang; Yu-Sun Chang; Yin-Kai Chao; Chi-Ju Yeh; Yun-Hen Liu; Chen-Kan Tseng; Hsien-Kun Chang; Yung-Liang Wan; Chuen Hsueh
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

6.  Biological and Clinicopathological Significance of Cripto-1 Expression in the Progression of Human ESCC.

Authors:  Reihaneh Alsadat Mahmoudian; Mohammad Reza Abbaszadegan; Mohammad Mahdi Forghanifard; Meysam Moghbeli; Faezeh Moghbeli; Jamshidkhan Chamani; Mehran Gholamin
Journal:  Rep Biochem Mol Biol       Date:  2017-04

7.  SOX2 and SOX12 are predictive of prognosis in patients with clear cell renal cell carcinoma.

Authors:  Weijie Gu; Beihe Wang; Fangning Wan; Junlong Wu; Xiaolin Lu; Hongkai Wang; Yao Zhu; Hailiang Zhang; Guohai Shi; Bo Dai; Dingwei Ye
Journal:  Oncol Lett       Date:  2018-01-19       Impact factor: 2.967

8.  Decrease of miR-146a is associated with the aggressiveness of human oral squamous cell carcinoma.

Authors:  Zonggao Shi; Jeffrey J Johnson; Rong Jiang; Yueying Liu; M Sharon Stack
Journal:  Arch Oral Biol       Date:  2015-06-20       Impact factor: 2.633

Review 9.  Functional and clinical significance of SALL4 in breast cancer.

Authors:  Ebubekir Dirican; Mustafa Akkiprik
Journal:  Tumour Biol       Date:  2016-07-21

10.  Auraptene Attenuates Malignant Properties of Esophageal Stem-Like Cancer Cells.

Authors:  Saffiyeh Saboor-Maleki; Fatemeh B Rassouli; Maryam M Matin; Mehrdad Iranshahi
Journal:  Technol Cancer Res Treat       Date:  2016-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.